Conversations regarding the challenges that Canadian life sciences and biomanufacturing companies face in accessing capital for biomanufacturing purposes.
Conversations regarding the importance of quality assurance and accuracy in point-of-care testing, sexually transmitted infections and cancer screening, and the federal biomanufacturing strategy.